TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Pain Therapeutics, Inc. (NASDAQ: PTIE) Investor Investigation Concerning Possible Wrongdoing Announced

  • Investors who purchased shares of Pain Therapeutics, Inc. (NASDAQ: PTIE) and currently hold any of those NASDAQ: PTIE shares have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Pain Therapeutics, Inc.
Security
NASDAQ: PTIE

Summary

An investigation on behalf of current long-term investors in shares of Pain Therapeutics, Inc. (NASDAQ: PTIE) was announced over potential breaches of fiduciary duties by certain officers and directors at Pain Therapeutics, Inc.

The investigation by a law firm concerns whether certain Pain Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Austin, TX based Pain Therapeutics, Inc. develops drugs for nervous system disorders in the United States. Shares of Pain Therapeutics, Inc. (NASDAQ: PTIE) declined from $21.00 per share on September 19, 2016 to as low as $3.15 per share in August 2017.

Start Monitoring Your Investments